Apr 28,2021

ASCENSIA ROLLS OUT THE ON@PRO ONLINE EDUCATIONAL PLATFORM FOR HEALTHCARE PROFESSIONALS IN COLLABORATION WITH THE TUMAINI INSTITUTE

Ascensia Diabetes Care, a leading global diabetes care company, has announced today that it has rolled out an online educational platform for continuous personal learning aimed at healthcare professionals working with people with diabetes. The On@Pro tool, which was originally piloted in September 2020, has been developed in partnership with the TUMAINI Institute in Germany, through a collaboration with Professor Peter Schwarz, a globally renowned diabetes expert.

View Analyst & Ambassador Comments
Go to original news
Apr 28,2021

my mhealth and collaborators awarded €2.5M Eurostars Grant for better heart health project

Immersive cardiac rehabilitation app, myHeart uses behavioural feedback and gamification features to improve patient well-being.

FUNDING GRANT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Apr 28,2021

Elizabeth McCombs Appointed Chief Technology Officer at BD

McCombs, 45, will be responsible for continuing to drive the BD's category innovation strategy and leading all research and development (R&D) activities, including executing the current innovation pipeline and developing the future product portfolio.

View Analyst & Ambassador Comments
Go to original news
Apr 29,2021

Nemaura Medical Issues Letter to Shareholders Following April 28 Shareholder Update Call

Nemaura Medical, Inc, a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today issues a Letter To Shareholders from CEO Dr. Faz Chowdhury summarizing its Shareholder Update call held yesterday, April 28, 2021.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Apr 29,2021

BD to Present at Upcoming Investor Health Care Conferences in May

BD, a leading global medical technology company, today announced that it will present at the following upcoming virtual investor healthcare conferences during the month of May

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 11,2021

MyWay Digital health: Accredited suppliers on the NHS England Health Systems Support Framework (HSSF)

MyWay Digital health is pleased to be included in the recent announcement of accredited suppliers on the NHS England Health Systems Support Framework (HSSF).

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
May 03,2021

Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations

The Company update presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 04,2021

Insulet to Present at BofA Securities 2021 Virtual Healthcare Conference

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the virtual BofA Securities 2021 Health Care Conference on Wednesday, May 12, 2021 at 4:15 p.m. (Eastern Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 05,2021

Tandem Diabetes Care Announces First Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2021 and updated its sales guidance for the year ending December 31, 2021.

View Analyst & Ambassador Comments
Go to original news
May 05,2021

Voluntis, A Pioneer-Turned-Leader in digital therapeutics, set out its ambitions for profitable growth

In 2011, Voluntis became the first company to sign a biopharmaceutical licensing agreement in the digital therapeutics industry and pioneered this emerging sector. At that time, Voluntis was the only company to have developed its own technology and convinced a global pharmaceutical company to combine this nascent technology with a medical treatment in order to increase the therapeutic effectiveness, improve the quality of life for patients and optimize follow-up by healthcare professionals.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES